Here are three facts to know:
1. Pfizer will collaborate with Exact Sciences’ sales representatives to promote Cologuard to physicians and health systems and expand Cologuard’s marketing campaign.
2. The two companies hope to increase colorectal cancer screening by accelerating the adoption of Cologuard.
3. Pfizer will co-promote Cologuard starting in the fourth quarter of 2018 and will share profits and marketing expenses equally on an agreed-upon baseline.
More articles on gastroenterology:
3 GIs share their thoughts on Exact Sciences’ Cologuard
4 notes on Lumendi’s newest executive Michael Thomas
These 5 specialties got the most fellowship applications in 2018 — Gastroenterology No. 4
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.